Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 16 | Longs Won 11/15 73% | Profit Factor 1.05 |
| Profitability | Shorts Won 0/1 0% | Standard Deviation $14,940.68 |
| Average Win $6,455.27 | Best Trade (Feb 16) $23,360.25 | Sharpe Ratio -25.69 |
| Average Loss -$13,481.24 | Worst Trade (Jan 08) -$47,369.7 | Z-Score 0.38 (29.67%) |
| Commissions $0 | Avg. Trade Length 2m 2w 2d | Expectancy $256.61 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 60.01% | 69.99% | 76.57% | 81.61% | 85.75% | 89.29% | 92.4% | 95.17% | 97.69% |
| Consecutive Losing Trades | 8 | 7 | 6 | 5 | 5 | 4 | 3 | 2 | 2 | 1 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics Inc. | 5,648.72 | $102,693.66 | $104,105.84 | - | $1,412.18 | 1.38% | +1.711% |